Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
about
The clinical significance of forkhead box protein A1 and its role in colorectal cancer.FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3β and activating Wnt signaling in bladder cancer cells.On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.Sleeping beauty: awakening urothelium from its slumber.FOXK1 facilitates cell proliferation through regulating the expression of p21, and promotes metastasis in ovarian cancer.FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.FOXK1 promotes glioblastoma proliferation and metastasis through activation of Snail transcription.The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression.Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.
P2860
Q37190816-35A107F0-D387-4776-8EF6-55ECE2FCC411Q37479778-D400C729-08AC-4928-AA0E-FECDBE1FD6ACQ37588256-D7B97C19-69C5-46C5-9741-FB13A3EDF3F2Q37725567-35EFD2EC-E4C1-4F0F-A91D-C0A169BE8CB7Q38627721-26C1CE4F-C8EF-4553-998A-826AAB8B5F23Q38731985-CA0E343D-FFFB-4695-A91F-356E218368FBQ38789453-5B1E9E40-4C59-40B0-AB06-F927770ACD2CQ39103374-C12B0313-E896-4DF2-B6FB-9D6E5DDC2C46Q42378442-47CF73FA-9101-46F3-9EA9-53851445174AQ42512532-907143A2-237A-42DA-9DAD-899DB32F9179Q47551371-8660DDCA-49C1-40D6-AAC5-25C3409DA8E4Q49875074-DB27161D-D124-4D48-B739-7D8B967594F2Q51011206-36959FA2-218A-4E0E-AAC8-DBA16E5FF570Q54978003-EFD3D144-9F03-4CC7-84D0-B0AA5FDED26DQ55265963-746D77BC-AAA8-421F-B7DB-EEF75A294FD8
P2860
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@ast
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@en
type
label
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@ast
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@en
prefLabel
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@ast
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@en
P2093
P2860
P50
P1476
Loss of FOXA1 Drives Sexually ...... r Prognosis in Bladder Cancer.
@en
P2093
Chaochen You
Daniel A Barocas
David J DeGraff
Henry S Crist
John A Taylor
Joseph A Smith
Klaus H Kaestner
Lan L Gellert
Michael S Cookson
P2860
P304
P356
10.1016/J.AJPATH.2015.01.014
P407
P577
2015-05-01T00:00:00Z